Access detailed search options for content from the Clinical Journal of Oncology Nursing & Oncology Nursing Forum below.
This redesigned and updated program was created with the new oncology advanced practice provider in mind. Through a series of four online courses, learners will get a comprehensive look at of the basics of cancer and its treatment, symptom and side effect management, and the identification of and management of oncologic emergencies with content designed for the advanced practice provider.
The ONS/ONCC Chemotherapy Immunotherapy Certificate Renewal Course will guide you through four strategically planned case studies to ensure that your chemotherapy and immunotherapy knowledge stays current and you’re continuing to progress as an experienced oncology RN.
The Fundamentals of Chemotherapy Immunotherapy Administration Renewal Course builds on the lessons you received in the Fundamentals of Chemotherapy Immunotherapy Administration Course to ensure that your chemotherapy and immunotherapy knowledge remains current and you’re continuing to progress as an experienced oncology RN.
Cancer care across the healthcare continuum has been revolutionized by advances in the understanding and application of genomics. The paradigm shift to biomarker-driven treatment decisions is a large step toward achieving precision oncology, which is the use of tumor-specific information, like genomic information, to inform cancer care.
Better understand the mechanism of action when combining anti-hormonal therapy and a CDK4/6 inhibitor as a dual inhibitor to treat metastatic breast cancer.
This course provides foundational knowledge on the basic principles of cancer and the evaluation and diagnosis of cancer for the advanced practice provider.
This module explores the considerations and principles of caring for older adults with cancer. Learn assessment tools, care modifications, pharmacologic principles, and treatment considerations specific to older adults with cancer, which will prepare advanced practice providers for the anticipated surge in survivors in this age group.